EP Patent

EP3727474A1 — Radiolabeling of polypeptides

Assigned to Janssen Biotech Inc · Expires 2020-10-28 · 6y expired

What this patent protects

Improved methods of radiolabeling antibodies using click chemistry are described. Also described are pharmaceutical compositions and uses related to the radiolabeled antibodies produced by the methods.

USPTO Abstract

Improved methods of radiolabeling antibodies using click chemistry are described. Also described are pharmaceutical compositions and uses related to the radiolabeled antibodies produced by the methods.

Drugs covered by this patent

Patent Metadata

Patent number: EP3727474A1
Jurisdiction: EP
Classification: —
Expires: 2020-10-28
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Biotech Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.